Vamsi Kota

National Cancer Center of Georgia — GE

Medicine · Health Sciences

25h-index2.8kcitations373works3.72yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Chronic Myeloid Leukemia Treatments(109), Acute Myeloid Leukemia Research(106), Acute Lymphoblastic Leukemia research(76), Chronic Lymphocytic Leukemia Research(68), Retinoids in leukemia and cellular processes(35)

Publications372 total

Fluoroquinolone Prophylaxis Reduces Intensive Care Unit Admission and <i>Clostridioides difficile</i> Rates in Acute Myeloid Leukemia Induction Chemotherapy
eJHaem·2026Open Access
Real-world toxicity of brexucabtagene autoleucel in adults with relapsed/refractory B-cell acute lymphoblastic leukemia
Blood Immunology & Cellular Therapy·2025Open Access
CO60 Comparative Real-World Effectiveness of Tyrosine Kinase Inhibitors as Induction Therapy for Philadelphia-Positive Acute Lymphoblastic Leukemia: A Multicenter Retrospective Study
Value in Health·2025
The utility of CT sinus screening in the pre-bone marrow transplant evaluation
Blood·2025
Bridging the gap: Evaluating the impact of satellite clinics on CAR-T therapy access in the rural Southeast
Blood·2025Open Access
Chest imaging prior to allogeneic bone marrow transplant: A retrospective study of pre-transplant workup outcomes
Blood·2025Open Access
Clinical and molecular characteristics of Philadelphia chromosome positive B-cell precursor acute lymphoblastic leukemia with central nervous system relapse versus systemic relapse: Results from consortium on myeloid malignancies and neoplastic diseases (COMMAND)
Blood·2025Open Access
Pre- or post-CAR-T allogeneic hematopoietic cell transplant provides relapse-free survival benefit for R/R Philadelphia negative B-cell acute lymphoblastic leukemia (B-ALL) successfully treated with brexucabtagene autoleucel in the real world
Blood·2025Open Access
Imatinib in chronic myeloid leukemia: A comparative assessment of patients in pivotal clinical trials and real-world settings
Blood·2025Open Access
Choice of hypomethylating agent for newly diagnosed TP53-mutant Acute Myeloid Leukemia: A command registry study
Blood·2025Open Access
Acrobat interim results: Alloheme surveillance enables early detection of relapse in post-HCT AML and MDS patients
Blood·2025Open Access
Outcomes for Primary Central Nervous System Lymphoma from a Single Institution
Hematology Reports·2025Open Access
Outcomes of older patients with TP53-mutated myeloid neoplasms
Blood Cancer Journal·2025Open Access
CAR HEMATOTOX independently predicts outcomes after CD19 CAR-T therapy for acute lymphoblastic leukemia
Blood Advances·2025· 1 citedOpen Access
Oncologists’ preferences for frontline TKI treatment of Ph+ acute lymphoblastic leukemia: a discrete choice experiment
Future Oncology·2025Open Access
Estimating the burden of chronic stress through allostatic load in patients with chronic myeloid leukemia
Leukemia·2025· 1 cited
Prevention of Early Death in Very Elderly Acute Promyelocytic Leukemia Patients Using Lower Induction Doses of All-trans Retinoic Acid
Mediterranean Journal of Hematology and Infectious Diseases·2025· 1 citedOpen Access
ALL-346: Impact of Patient Profiles on Hematologist-Oncologists’ Preferences for Treating Newly Diagnosed Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia (Ph+ ALL) Using Tyrosine Kinase Inhibitors (TKI) in Combination With Chemotherapy: A Discrete Choice Experiment
Clinical Lymphoma Myeloma & Leukemia·2025
POSTER: ALL-346 Impact of Patient Profiles on Hematologist-Oncologists’ Preferences for Treating Newly Diagnosed Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia (Ph+ ALL) Using Tyrosine Kinase Inhibitors (TKI) in Combination With Chemotherapy: A Discrete Choice Experiment
Clinical Lymphoma Myeloma & Leukemia·2025
POSTER: CT-894 Incidence of Cytokine Release Syndrome-Associated Coagulopathy and Disseminated Intravascular Coagulation Following CAR-T Therapy: A Systematic Review and Meta-Analysis
Clinical Lymphoma Myeloma & Leukemia·2025
page 1 of 19Next →

Frequent Co-authors

Ravindra Kolhe(13), Ashis K. Mondal(11), Jörge E. Cortes(10), Pankaj Ahluwalia(9), Nikhil Sahajpal(9), Amyn M. Rojiani(8), Michael W. Deininger(6), Ehab Atallah(6), Meenakshi Ahluwalia(6), Carlo Gambacorti‐Passerini(5), Michael J. Mauro(5), Sudha Ananth(5), Danielle Bradshaw(5), Tim H. Brümmendorf(4), Philippe Rousselot(4), Andreas Hochhaus(4), Eric Leip(4), Mark R. Litzow(4), Anand Jillella(4), Elliott F. Winton(4)